INS and type 1 diabetes mellitus: In summary, there is an unmet medical need for treatments that address the root cause of diseases rather than replacing the loss of βcell function with an exogenous replacement therapy that requires constant monitoring of glucose levels and a dosing regimen of insulin, particularly in the case of T1D.